Octreotide (Pediatric)
A synthetic analogue of somatostatin. It inhibits the release of insulin, growth hormone, and various gut hormones.
Dosage by Body Weight
Pediatric dose: 1 mcg/kg to 10 mcg/kg every 6 to 12 hours (subcutaneous).
- Body Weight
- 3-10 kg (Infant)
- Dose
- 5 mcg to 50 mcg
- Frequency
- Every 6 to 8 hours
- Tracking Notes
- May cause gallbladder sludge or stones with long-term use.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| 3-10 kg (Infant) | 5 mcg to 50 mcg | Every 6 to 8 hours | May cause gallbladder sludge or stones with long-term use. |
Formulation
Purpose
Treatment of persistent hyperinsulinemic hypoglycemia in infants and control of certain types of diarrhea.
Generic Name
Octreotide AcetateBranded Drug Names
Octreotide (Pediatric) is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:
Scheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.
Alternatives
Safety Advice
Alcohol
CAUTIONOctreotide (Pediatric): Alcohol can affect blood sugar, hormones, or dehydration risk. Avoid or limit alcohol and follow your clinician advice.
Pregnancy
SAFE IF PRESCRIBEDOctreotide (Pediatric): Use during pregnancy only with specialist guidance; dose needs may change and monitoring is important.
Breast Feeding
SAFE IF PRESCRIBEDOctreotide (Pediatric): Use while breastfeeding only as directed; endocrine treatments often require ongoing clinical monitoring.
Driving
CAUTIONOctreotide (Pediatric): May affect alertness indirectly through low blood sugar, dizziness, or hormone imbalance. Avoid driving if symptoms occur.
Liver
CAUTIONOctreotide (Pediatric): Use with medical guidance in liver disease, especially when metabolism or blood sugar control may be affected.
Kidney
CAUTIONOctreotide (Pediatric): Kidney disease can change dosing or monitoring needs for several endocrine medicines.